14. Stock Compensation (Details - Grant vesting periods) - Common Stock Grants [Member] - USD ($) |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2020 |
Dec. 31, 2019 |
|
Common stock grants outstanding | 512,501 | 512,501 |
Unrecognized stock compensation expense | $ 310,243 | |
Grant 1 [Member] | ||
Common stock grants outstanding | 264,167 | |
Unrecognized stock compensation expense | $ 183,125 | |
Vesting period | 1 year | |
Grant 2 [Member] | ||
Common stock grants outstanding | 148,334 | |
Unrecognized stock compensation expense | $ 93,784 | |
Vesting period | 2 years | |
Grant 3 [Member] | ||
Common stock grants outstanding | 100,000 | |
Unrecognized stock compensation expense | $ 33,333 | |
Vesting period | 3 years |
X | ||||||||||
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|